NCT05704985 2025-05-29
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
Phase 1 Active not recruiting
DEKA Biosciences
Thomas Jefferson University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
University of California, San Francisco